Alto Neuroscience, Inc. Net Asset Momentum
Alto Neuroscience, Inc. net asset momentum. Alto Neuroscience, Inc. (ANRO) recorded a net asset momentum of -0.2% as of September 2025, with net assets of $151.14 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Alto Neuroscience, Inc. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Alto Neuroscience, Inc. (2021–2025)
Net asset momentum of Alto Neuroscience, Inc. from 2021 to 2025. This chart tracks Alto Neuroscience, Inc.'s year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -0.2%, with net assets of $151.14 Million USD as of September 2025. See net assets of Alto Neuroscience, Inc. for net asset value and shareholders' equity analysis.
Alto Neuroscience, Inc. Net Asset Momentum by Year (2021–2025)
Alto Neuroscience, Inc. net asset momentum by year from 2021 to 2025. The table below shows the complete annual net asset history for Alto Neuroscience, Inc. from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see ANRO market cap.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $151.14 Million | $184.69 Million | $33.55 Million | ▼ -0.2% |
| 2024 | $151.46 Million | $177.54 Million | $26.08 Million | ▲ +311.3% |
| 2023 | $-71.67 Million | $86.63 Million | $158.30 Million | ▼ -86.6% |
| 2022 | $-38.41 Million | $50.85 Million | $89.26 Million | ▼ -207.8% |
| 2021 | $-12.48 Million | $28.79 Million | $41.27 Million | — |